Last reviewed · How we verify
Non selective beta blocker - Propranolol — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Non selective beta blocker - Propranolol (Non selective beta blocker - Propranolol) — Hadassah Medical Organization.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Non selective beta blocker - Propranolol TARGET | Non selective beta blocker - Propranolol | Hadassah Medical Organization | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Non selective beta blocker - Propranolol CI watch — RSS
- Non selective beta blocker - Propranolol CI watch — Atom
- Non selective beta blocker - Propranolol CI watch — JSON
- Non selective beta blocker - Propranolol alone — RSS
Cite this brief
Drug Landscape (2026). Non selective beta blocker - Propranolol — Competitive Intelligence Brief. https://druglandscape.com/ci/non-selective-beta-blocker-propranolol. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing